A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.» Read More
If Amendment 64, which legalizes Marijuana and regulates it like alcohol, passes in Colorado this November, the state could see $64 million more in taxes, reports CNBC's Brian Shactman.
A provision of the Affordable Care Act squeezes premiums that drugmakers collect from the government has yielded savings of $687 million in the first six months of 2012.
The "Mad Money" host gets poetic and gives investors a glimpse of how the global economy might be seen through Charles Dickens' eyes.
With the weight loss market heating up, stocks like Arena Pharmaceuticals may be spelling out a big rally for the drug retail space.
Last week, Celgene announced it was pulling its Revlimid application in Europe, and Mad Money host Jim Cramer explains why he thinks investors should buy into the stock now.
The “Mad Money” host offers his earnings expectations for Time Warner, CVS Caremark, Garmin, Allergan and Clorox.
The drug developer's stock took a hit Thursday, after data was released linking an ingredient in its weight loss treatment to an increased risk of birth defects.
Accused of running a $7B ponzi scheme, Allen Stanford was in court today and CNBC's Scott Cohn has the story.
The "Mad Money" host reveals what earnings and other event he plans to monitor.
CNBC's Courtney Reagan reports on lifted holiday retail sales at drug stores.
Joseph Papa sits down with Cramer and explains why things are looking good for the private label drug maker.
Mad Money host Jim Cramer says every portfolio should have some defensive, recession-resistant stocks, with Greg Wasson, Walgreens CEO.
Ahead of its earnings report in mid-August, the retailer has announced plans to add 6,300 employees. Some early birds have jumped in to buy more than 6,000 August 50 calls for $1.63.
Blu, the maker of electronic cigarettes that release a nicotine-laden vapor instead of smoke, has developed packs of e-cigarettes with sensors that will let users know when other e-smokers are nearby, the New York Times reports.
Cramer explains when it's never a good idea to abandon turbo-charged growth stocks.
CNBC's Darren Rovell has an update on GNC's IPO pricing.
Why the "Fast Money" traders are monitoring these market moving stocks.
Don't get lost on the highways of investing. Here's how Cramer plans to navigate the days to come.